Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

NCT01189526 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

NETWORK

Sponsor class

Conditions

Branch Retinal Vein Occlusion

Interventions

DRUG: Ranibizumab
PROCEDURE: macular laser photocoagulation

Sponsor

Seoul Retina Investigator Group

Collaborators

[object Object]
[object Object]